FTC Warns 24 Largest Healthcare Firms of Enforcement Over Incomplete Price Disclosures

The October 5 letters and forum remarks restate the 2020 CMS price transparency rule while shifting enforcement emphasis to the FTC's Section 5 powers. Only 18 percent of hospitals currently post dollar amounts for at least half their services, per the Patient Rights Advocate September 2024 scan. Large machine-readable files remain difficult to parse, and ancillary fees are frequently omitted, producing the precise information asymmetry the statute targets. Ferguson indicated active investigations are underway, focused on rural, senior, and veteran populations where switching costs are highest.

Hospitals gain from maintaining list-price opacity because it preserves chargemaster-based reimbursement differentials across payers. Full compliance risks accelerating site-of-service shifts and reference pricing by employers, compressing margins on high-margin elective lines. The agency gains political credit for consumer protection without new legislation and can point to measurable uptake in shoppable services as evidence of regulatory efficacy.

The next observable threshold is the share of the 24 recipients that publish usable, all-in prices by the first quarter of 2026. If that share remains below 60 percent, the FTC has already signaled it will convert warning letters into administrative complaints. Parallel state attorney general actions are likely to follow identical fact patterns.